Council on the Kidney in Cardiovascular Disease (KCVD)
Message from the Chair
Welcome to the Council for the Kidney in Cardiovascular Disease (KCVD). Our Council strives to reduce cardiovascular-related disability and death through clinical, translational, and basic research, communication, advocacy and education relevant to: a) the role of the kidney in hypertension, b) the role of the kidney in cardiovascular diseases – this includes acute kidney injury and chronic kidney disease and its effects on heart disease, stroke, and peripheral vascular disease, c) the specific role of the kidney in diabetes-induced cardiovascular disease, and d) cardio-renal syndrome.
Alexander Staruschenko, PhD, FAHA
Chair, Council on Kidney in Cardiovascular Disease
News and Information from the KCVD Council
Hypertension Scientific Sessions 2021
Sept. 27–29, 2021A Virtual Event
Scientific Sessions 2021
November 13-15, 2021
Boston, MA + Virtual
Science News
AHA Professional Members are Difference Makers
Funding Opportunities
The method for applying for funding is Web-based, using our electronic system, ProposalCentral.
Hypertension
Hypertension is one of 11 AHA journals. It represents the Councils on HBPR and KCVD, in cooperation with the Inter-American Society of Hypertension.